-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Buy on Lexicon Pharmaceuticals, Raises Price Target to $3.4

Benzinga·11/09/2026 18:52:14
Listen to the news
Citigroup analyst Yigal Nochomovitz maintains Lexicon Pharmaceuticals (NASDAQ:LXRX) with a Buy and raises the price target from $3.1 to $3.4.